Page 78 - Vitamin D and Cancer

3 Anti-inflammatory Activity of Calcitriol in Cancer 65

8. Bartsch H, Nair J (2004) Oxidative stress and lipid peroxidation-derived DNA-lesions in
inflammation driven carcinogenesis. Cancer Detect Prev 28(6):385–391
9. Hussein MR, Ahmed RA (2005) Analysis of the mononuclear inflammatory cell infiltrate in
the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative
lesions of the skin. Cancer Biol Ther 4(8):819–821
10. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A (2008) Pathways connecting
inflammation and cancer. Curr Opin Genet Dev 18(1):3–10
11. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature
454(7203):436–444
12. Lucia MS, Torkko KC (2004) Inflammation as a target for prostate cancer chemoprevention:
pathological and laboratory rationale. J Urol 171(2 Pt 2):S30–S34, discussion S5
13. Mantovani A, Pierotti MA (2008) Cancer and inflammation: a complex relationship. Cancer
Lett 267(2):180–181
14. Kundu JK, Surh YJ (2008) Inflammation: gearing the journey to cancer. Mutat Res
659(1–2):15–30
15. Moran EM (2002) Epidemiological and clinical aspects of nonsteroidal anti-inflammatory
drugs and cancer risks. J Environ Pathol Toxicol Oncol 21(2):193–201
16. Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer
agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94(4):252–266
17. Colston KW, Welsh J (2005) Vitamin D and breast cancer. In: Feldman D, Pike JW, Glorieux
FH (eds) Vitamin D. Elsevier Academic Press, San Diego, pp 1663–1677
18. Cross HS (2005) Vitamin D and colon cancer. In: Feldman D, Pike JW, Glorieux FH (eds)
Vitamin D. Elsevier Academic Press, San Diego, pp 1709–1725
19. Gombart AF, Luong QT, Koeffler HP (2006) Vitamin D compounds: activity against
microbes and cancer. Anticancer Res 26(4A):2531–2542
20. Gonzalez-Sancho JM, Larriba MJ, Ordonez-Moran P, Palmer HG, Munoz A (2006) Effects
of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res
26(4A):2669–2681
21. Gross MD (2005) Vitamin D and calcium in the prevention of prostate and colon cancer: new
approaches for the identification of needs. J Nutr 135(2):326–331
22. Harris DM, Go VL (2004) Vitamin D and colon carcinogenesis. J Nutr 134(12
Suppl):3463S–3471S
23. Krishnan AV, Peehl DM, Feldman D (2003) Inhibition of prostate cancer growth by vitamin
D: Regulation of target gene expression. J Cell Biochem 88(2):363–371
24. Krishnan AV, Peehl DM, Feldman D (2005) Vitamin D and prostate cancer. In: Feldman D,
Pike JW, Glorieux FH (eds) Vitamin D, 2nd edn. Elsevier Academic Press, San Diego,
pp 1679–1707
25. Luong QT, Koeffler HP (2005) Vitamin D compounds in leukemia. J Steroid Biochem Mol
Biol 97(1–2):195–202
26. Mordan-McCombs S, Valrance M, Zinser G, Tenniswood M, Welsh J (2007) Calcium, vita-
min D and the vitamin D receptor: impact on prostate and breast cancer in preclinical mod-
els. Nutr Rev 65(8 Pt 2):S131–S133
27. Schwartz GG, Skinner HG (2007) Vitamin D status and cancer: new insights. Curr Opin Clin
Nutr Metab Care 10(1):6–11
28. Stewart LV, Weigel NL (2004) Vitamin D and prostate cancer. Exp Biol Med (Maywood)
229(4):277–284
29. Welsh J (2007) Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner
Res 22(Suppl 2):V86–V90
30. Fleet JC (2008) Molecular actions of vitamin D contributing to cancer prevention. Mol
Aspects Med 29(6):388–396
31. Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D (2007)
Novel pathways that contribute to the anti-proliferative and chemopreventive activities of
calcitriol in prostate cancer. J Steroid Biochem Mol Biol 103(3–5):694–702